Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo A Licata

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Aerospace Medicine and Human Performance|June 24, 2015
Challenges of Estimating Fracture Risk with DXA: Changing Concepts About Bone Strength and Bone DensityAngelo A Licata
Drugs & Aging|July 31, 2007
Clinical perspectives on bone quality in osteoporosis: effects of drug therapyAngelo A Licata
Orthopedic Nursing|June 1, 2007
Update on therapy for osteoporosisAngelo A Licata
Cleveland Clinic Journal of Medicine|May 20, 2006
Diagnosing primary osteoporosis: it's more than a T scoreAngelo A Licata
The New England Journal of Medicine|May 6, 2005
Osteoporosis, teriparatide, and dosing of calcium and vitamin DAngelo A Licata
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 22, 2005
Systemic effects of fluticasone nasal spray: report of 2 casesAngelo A Licata
American Journal of Obstetrics and Gynecology|November 13, 2012
Bone density, bone quality, and FRAX: changing concepts in osteoporosis managementAngelo A Licata
Cleveland Clinic Journal of Medicine|October 23, 2008
Biochemical markers of bone turnover: useful but underusedAngelo A Licata
The Annals of Pharmacotherapy|March 10, 2005
Discovery, clinical development, and therapeutic uses of bisphosphonatesAngelo A Licata
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 31, 2010
Gastrointestinal side effects of bisphosphonates obscuring vascular diseaseVinni Grover, Angelo A Licata
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Aerospace Medicine and Human Performance|June 24, 2015
Challenges of Estimating Fracture Risk with DXA: Changing Concepts About Bone Strength and Bone DensityAngelo A Licata
Drugs & Aging|July 31, 2007
Clinical perspectives on bone quality in osteoporosis: effects of drug therapyAngelo A Licata
Orthopedic Nursing|June 1, 2007
Update on therapy for osteoporosisAngelo A Licata
Cleveland Clinic Journal of Medicine|May 20, 2006
Diagnosing primary osteoporosis: it's more than a T scoreAngelo A Licata
The New England Journal of Medicine|May 6, 2005
Osteoporosis, teriparatide, and dosing of calcium and vitamin DAngelo A Licata
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 22, 2005
Systemic effects of fluticasone nasal spray: report of 2 casesAngelo A Licata
American Journal of Obstetrics and Gynecology|November 13, 2012
Bone density, bone quality, and FRAX: changing concepts in osteoporosis managementAngelo A Licata
Cleveland Clinic Journal of Medicine|October 23, 2008
Biochemical markers of bone turnover: useful but underusedAngelo A Licata
The Annals of Pharmacotherapy|March 10, 2005
Discovery, clinical development, and therapeutic uses of bisphosphonatesAngelo A Licata
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 31, 2010
Gastrointestinal side effects of bisphosphonates obscuring vascular diseaseVinni Grover, Angelo A Licata
Pageof 3